Health Care & Life Sciences » Pharmaceuticals | Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$982.72 M
Shares Outstanding
47.07 M
Public Float
34.04 M


11570 6th Street
Rancho Cucamonga California 91730
United States
Employees -
Updated 07/08/2019
Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs.


View All

Zi Ping Luo
Chairman, COO & Chief Scientist
Jason B. Shandell
President, Director & General Counsel